BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/28/2026 5:56:57 AM | Browse: 2 | Download: 0
Publication Name World Journal of Experimental Medicine
Manuscript ID 121046
Country United States
Category Cardiac & Cardiovascular Systems
Manuscript Type Minireviews
Article Title Genetic and biological determinants of pulmonary embolism: Insights from Mendelian randomization studies
Manuscript Source Unsolicited Manuscript
All Author List Rupak Desai, Darsh Patel, Abhishek Prasad, Navya Mandalapu, Jai Nagarajan, Ananth Guddeti, Sourabh Khatri, Warda Shahnawaz, Abdul Aleem, Adil S Mohammed, Umera Yasmeen and Muhammad Usman Ghani
Funding Agency and Grant Number
Corresponding Author Muhammad Usman Ghani, Assistant Professor, MD, Medicine, Central Michigan University College of Medicine, 1632 Stone St, Saginaw, MI 48602, United States. usmanghani162@gmail.com
Key Words Pulmonary embolism; Mendelian randomization; Matrix metalloproteinases; Immune dysregulation; Renal dysfunction; Genetic epidemiology; Thrombosis; Risk factors
Core Tip Mendelian randomization evidence indicates that matrix metalloproteinases (MMP)-19 may be associated with increased risk of pulmonary embolism (PE), while MMP-12 may exhibit an inverse association. Reduced kidney function appears to have a potential genetic association with PE susceptibility. Immune pathways involving HLA-DR-positive natural killer cell traits and gut microbiota-related factors, such as Clostridium innocuum, Butyricicoccus, and Actinobacteria, may also contribute to PE susceptibility. In contrast, no consistent associations were observed for type 2 diabetes mellitus, atrial fibrillation, or epigenetic age acceleration. These findings underscore emerging biological pathways in PE; however, they should be interpreted cautiously, as they are hypothesis-generating and require further validation.
Citation Desai R, Patel D, Prasad A, Mandalapu N, Nagarajan J, Guddeti A, Khatri S, Shahnawaz W, Aleem A, Mohammed AS, Yasmeen U, Ghani MU. Genetic and biological determinants of pulmonary embolism: Insights from Mendelian randomization studies. World J Exp Med 2026; In press
Received
2026-03-16 00:43
Peer-Review Started
2026-03-16 00:47
First Decision by Editorial Office Director
2026-03-27 10:47
Return for Revision
2026-03-27 10:47
Revised
2026-04-13 17:06
Publication Fee Transferred
2026-04-17 13:35
Second Decision by Editor
2026-04-28 02:42
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-04-28 05:56
Articles in Press
2026-04-28 05:56
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2220-315x (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com